Pharmaceutical Industries

GMP-regulated manufacture of finished dosage forms, APIs, and packaging at commercial scale.

Innovation-driven companies developing biologics, cell and gene therapies, and platform technologies.

Design and execution of human trials across phases I–IV.

Sponsor and CRO-led trials evaluating safety and efficacy of investigational therapies.

Design, manufacture, and regulation of Class I–III medical devices including IVDs.

Discovery, development, and large-scale manufacture of prophylactic and therapeutic vaccines.

In-vitro diagnostics, molecular diagnostics, and companion diagnostic development.

Target identification through candidate nomination across small molecules and biologics.

Preclinical and clinical development of investigational medicinal products.

ANDA-driven development and manufacture of generic finished products.

Complex therapies for rare and chronic conditions including limited-distribution products.

Injectables, sterile products, and specialty therapeutics for institutional use.

Outsourced clinical, preclinical, and lab services for biopharma sponsors.

Outsourced API and finished-product development and GMP manufacture.

Strategy and operations for product approvals across global health authorities.

Safety surveillance, signal detection, and aggregate safety reporting.

Quality systems, audits, deviations, and CAPA across GxP environments.

Analytical testing and release of raw materials, in-process, and finished products.

All GMP-regulated manufacturing operations across solid, liquid, sterile, and biologics.

Synthesis and purification of active pharmaceutical ingredients at scale.

Upstream/downstream development and manufacture of monoclonal antibodies, recombinant proteins, and biosimilars.

Autologous and allogeneic cell therapies including CAR-T platforms.

AAV, lentiviral, and gene-editing therapies from discovery to commercial.

Biomarker-driven therapies and companion diagnostics.

Software as a medical device, digital therapeutics, and decentralized trials technology.

Broad ecosystem spanning research tools, services, and therapeutic development.

Health IT, EHR, and clinical decision support platforms.

Capital medical equipment and consumables manufacturing.

Central labs, bioanalytical services, and specialty testing.

Computational biology, NGS analytics, and AI/ML for drug discovery.

End-to-end pharmacovigilance and patient safety operations.

EDC, data review, and database lock activities across global trials.

Real-world evidence, HEOR, and commercial analytics.